Form 4: Phreesia Inc. Executive David Linetsky Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
David Linetsky, SVP of Life Sciences at Phreesia Inc., sold 269 shares of common stock on April 18, 2024, to cover tax withholding obligations related to the settlement of restricted stock units.
Summary
- On April 18, 2024, David Linetsky, SVP of Life Sciences at Phreesia Inc., disposed of 269 shares of common stock.
- The sale was executed to cover tax withholding obligations associated with the settlement of restricted stock units.
- The shares were sold at a weighted average price of $22.847 per share, with individual transactions ranging from $22.56 to $23.19.
- Following the transaction, Linetsky directly owns 204,038 shares and indirectly owns 7,087 shares through a spouse.
Sentiment
Score: 5
Explanation: The document is a standard SEC Form 4 filing, indicating a routine transaction. It doesn't inherently convey positive or negative sentiment.
Industry Context
Executive stock sales are a common occurrence and can be for various reasons, including diversification, tax obligations, or personal financial planning. This transaction appears to be related to tax obligations from settled restricted stock units.
Stakeholder Impact
- The sale of a small number of shares by an executive is unlikely to have a significant impact on shareholders.
Key Dates
| Date | Description |
|---|---|
| 04/18/2024 | Date of the transaction: David Linetsky sold 269 shares of Phreesia Inc. common stock. |
| 04/19/2024 | Date of report filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.